Development of Optical Biometer

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCassini Technologies

About this trial

The Helioscope (Cassini Technologies B.V.) is a novel device under development that aims at combining LED-based corneal topography and SS-OCT to provide accurate and fast measurements of both the corneal shape and the ocular biometry. To that end, the hardware and software of the Cassini color-LED topographer (Cassini Technologies B.V.) is combined with a novel SS-OCT device.

While the new Helioscope can largely be evaluated using data acquired with healthy eyes, one of its main use-cases is providing input for IOL power formulae for cataract surgery. Thus, it is essential that the device can perform measurements in eyes with (dense) cataract. As cataract changes the optical properties of the crystalline lens and the OCT measurement is optical, this is not a given. This study therefore seeks a dataset of Helioscope measurements performed in eyes with cataract that can be used to develop the software algorithms of the Helioscope.

Eligibility criteria

Qualifiers

The presence of cataract in at least one eye.

Minimally 21 years of age.

Provided written informed consent.

Disqualifiers

The inability to properly fixate on a fixation target for several seconds

The inability to provide informed consent.

Trial design

Treatments tested in this trial

  • New Investigational Optical Biometer (Device)
  • Comparator Device A (Cassini Ambient)
  • omparator Device B (Argos)

Treatment groups

100 Participants
are divided into 1 treatment group

Sponsors and collaborators